WWWanzhou Wu

Wanzhou Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wanzhou Wu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Yongping Bai

    Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, China

    3 shared publications
  • Chuanchang Li

    Department of Geriatric Medicine, Center of Coronary Circulation, Xiangya Hospital, Central South University, Xiangya Rd No. 87, Changsha, 410008, China.

    2 shared publications
  • Jin Li

    National Clinical Research Center for Geriatric Disease, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

    2 shared publications
  • Jing Chen

    Coronary Circulation Center, Xiangya Hospital, Central South University, Changsha, China

    2 shared publications
  • Xuan Wang

    National Clinical Research Center for Geriatric Disease, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

    2 shared publications
  • Yue Wang

    National Clinical Research Center for Geriatric Disease, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

    2 shared publications

Latest Publications

  • Open Access

    HK2 promotes angiogenesis through H3K18 lactylation in peripheral arterial disease

    by Jing Chen, Yue Wang, Xuan Wang, Jin Li, Yu Liu, Jipeng Zhou, Chuanchang Li, Wanzhou Wu, Yongping Bai

    Peripheral arterial disease (PAD) is characterized by impaired angiogenesis, yet the molecular mechanisms linking metabolic dysregulation to epigenetic reprogramming in endothelial cells (ECs) remain poorly understood. Here, we identify hexokinase 2 (HK2) as a critical regulator of angiogenesis through histone lactylation in PAD. In clinical specimens and murine hindlimb ischemia (HLI) models, HK2 expression was significantly downregulated. Functional assays in hypoxia-serum starved (HSS) human umbilical vein ECs (HUVECs) demonstrated that HK2 overexpression rescued angiogenesis by enhancing proliferation, migration, tube formation, and pro-angiogenic protein expression (VEGFA), while HK2 knockdown suppressed these phenotypes. Mechanistically, HK2 deficiency selectively reduced histone H3 lysine 18 lactylation (H3K18la) among eight tested histone lactylation sites, and HK2 restoration under HSS restored H3K18la level. Exogenous lactate reversed angiogenic defects in HK2-knockdown HUVECs by elevating H3K18la, which directly activated VEGFA transcription, as shown by Chromatin Immunoprecipitation coupled with quantitative Polymerase Chain Reaction (ChIP-qPCR). Furthermore, Sirtuin 2 (SIRT2), as a de-lactylase, inhibition in HK2-knockdown HUVECs restored H3K18la, angiogenesis, and pro-angiogenic protein expression. In HLI mice, SIRT2 inhibitor treatment improved blood flow recovery, increased EC density, and upregulated H3K18la. Our findings establish HK2 as a metabolic-epigenetic nexus driving angiogenesis via lactate-dependent H3K18la modification and propose SIRT2 inhibition as a novel therapeutic strategy to bypass HK2 deficiency in PAD.


  • Open Access

    TRPM7 Deficiency Accelerates Vascular Senescence by Inhibiting H3K18 Lactylation

    by Yue Wang, Jing Chen, Xuan Wang, Jin Li, Shujun Yang, Lingping Zhu, Zhenyu Li, Chuanchang Li, Wanzhou Wu, Yongping Bai

    Blood vessels exhibit a pronounced vulnerability to aging and are often at the forefront of systemic aging processes. Vascular endothelial cells, which line blood vessels and directly contact blood flow, are susceptible to damage and play a key role in vascular aging; however, the underlying mechanisms of their aging remain unclear. Here, we identify TRPM7 as a key molecule in vascular endothelial aging. Endothelial deletion of TRPM7 significantly accelerates premature vascular aging in mice. Mechanistically, TRPM7 deficiency reduces lactate production and inhibits the lactylation writer protein p300, leading to decreased histone H3K18 lactylation. This induces a gene expression profile reprogramming, increasing the expression of the senescence gene p21 and decreasing the expression of angiogenesis genes. Inhibiting p21 or supplementing lactate reversed premature vascular endothelial aging caused by TRPM7 deficiency. This study reveals the critical role of the TRPM7‐H3K18la axis in vascular aging, offering potential therapeutic targets for vascular anti‐aging interventions.


  • Hypoxia activates macrophage‐ NLRP3 inflammasome promoting atherosclerosis via PFKFB3 ‐driven glycolysis

    by Xuan Wang, Xiangbin Liu, Wanzhou Wu, Longshen Liao, Ming Zhou, Xiaobo Wang, Zeming Tan, Guogang Zhang, Yongping Bai, Xiang Li, et al.

    The onset and progression of atherosclerosis are closely linked to the involvement of macrophages. While the contribution of NLRP3 inflammasome activation to the creation of a local highly inflammatory microenvironment is well recognized, the precise triggers remain unclear. In this study, we aimed to investigate the regulatory mechanism of NLRP3 inflammasome activation in response to hypoxia‐induced glycolysis involving PFKFB3 in the development of atherosclerosis. To develop an atherosclerosis model, we selected ApoE knockout mice treated with a high‐fat western diet. We then quantified the expression of HIF‐1α, PFKFB3, and NLRP3. In addition, we administered the PFKFB3 inhibitor PFK158 during atherosclerosis modeling. The glycolytic activity was subsequently determined through 18 F‐FDG micro‐PET/CT, ex vivo glucose uptake, and ECAR analysis. Furthermore, we employed lipopolysaccharide (LPS) and TNF‐α to induce the differentiation of bone marrow‐derived macrophages (BMDMs) into M1‐like phenotypes under both hypoxic and normoxic conditions. Our histological analyses revealed the accumulation of PFKFB3 in human atherosclerotic plaques, demonstrating colocalization with NLRP3 expression and macrophages. Treatment with PFK158 reduced glycolytic activity and NLRP3 inflammasome activation, thereby mitigating the occurrence of atherosclerosis. Mechanistically, hypoxia promoted glycolytic reprogramming and NLRP3 inflammasome activation in BMDMs. Subsequent blocking of either HIF‐1α or PFKFB3 downregulated the NLRP3/Caspase‐1/IL‐1β pathway in hypoxic BMDMs. Our study demonstrated that the HIF‐1α/PFKFB3/NLRP3 axis serves as a crucial mechanism for macrophage inflammation activation in the emergence of atherosclerosis. The therapeutic potential of PFKFB3 inhibition may represent a promising strategy for atheroprotection.